| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2445.75 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2829.81 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 2139.94 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 2651.17 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2916.91 | 99 |
| GSM780721 | Untreated after 4 days (C3_2) | 2326.92 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2907.34 | 99 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 3279.31 | 99 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2651.17 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 3105.04 | 99 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 3177.71 | 99 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 3110.15 | 99 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2397.3 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2256.87 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2484.16 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2575.54 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2342.5 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2588.44 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 3343.55 | 99 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2899.87 | 99 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 3301.02 | 99 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 3137.1 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 3089.75 | 99 |